Skip to main content
SpringerLink
Log in

Immunology and colonic cancer: Cancer immunotherapy results in leukemias-experimental and clinical approaches to the treatment of solid tumors

  • Symposium
  • Published:
Diseases of the Colon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alexander P, Connell DI, Mikulska ZB: Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor. Cancer Res 26:1508, 1966

    PubMed  CAS  Google Scholar 

  2. Alexander P, Delorme EJ, Hall JG: The effect of lymphoid cells from the lymph of specifically immunised sheep on the growth of primary sarcomata in rats. Lancet 1:1186, 1966

    Article  Google Scholar 

  3. Alexander P, Delorme EJ, Hamilton LD, et al: Effect of nucleic acids from immune lymphocytes on rat sarcomata. Nature 213:569, 1967

    Article  PubMed  CAS  Google Scholar 

  4. Amiel JL, Berardet M: Essais de traitements de la leucémie E ♂ G2 associant chimiothérapie et immunothérapies actives non spécifique et spécifique. Rev. Fr Étud Clin Biol 14:685, 1969

    PubMed  CAS  Google Scholar 

  5. Amiel JL, Méry AM, Mathé G: Les réponses immunitaires chez les patientes atteintes de choriocarcinome placentaire. Corrélation entre ces réponses et l'évolution de la maladie, Biological Immunosuppressive Agents. Liege, University of Leige, 1967, volume 1, p 197

    Google Scholar 

  6. Ankerst J: Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors. Cancer Res 31:997, 1971

    PubMed  CAS  Google Scholar 

  7. Baldwin RW, Glaves D, Pimm MV, et al: Tumour specific and embryonic antigen expression on chemically induced rat tumours, Cancer et Immunité. Paris, Masson, 1972, volume A, p 715

    Google Scholar 

  8. Belpomme D, le Borgne de Kaouel C, Ajuria E, et al: Increase in antigenicity of permanent tissue culture lines ICI 101, ICI 104 and ICI 202 established from human leukaemic blood. Nature 222:890, 1969

    Article  PubMed  CAS  Google Scholar 

  9. Bloom ET: Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylchol anthrene. J Natl Cancer Inst 45:443, 1970

    PubMed  CAS  Google Scholar 

  10. Bluming AZ, Vogel CL, Ziegler JL, et al: Immunological effects of BCG in malignant melanoma: Two modes of administration compared. Ann Intern Med 76:405, 1972

    PubMed  CAS  Google Scholar 

  11. Boone CW: Augmented immunogenicity of tumor cell homogenates infected with influenza virus (in press)

  12. Currie GA, Bagshawe KD: Active immunotherapy withCorynebacterium parvum and chemotherapy in murine fibrosarcomas. Br Med J 1:541, 1970.

    Article  PubMed  CAS  Google Scholar 

  13. Evans R, Alexander P: Cooperation of immune lymphoid cells with macrophages in tumour immunity. Nature 228:620, 1970

    Article  PubMed  CAS  Google Scholar 

  14. Foley EJ: Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 13:835, 1953

    PubMed  CAS  Google Scholar 

  15. Hellström I, Taranger LA, Chapman WH, et al: Murine bladder tumors as models for human tumor immunity (in press)

  16. Hellström KE, Hellström I: Immunologic defenses against cancer. Hosp Practice 5:45, 1970

    Google Scholar 

  17. Holland JF, St Arneault G, Bekesi G: Combined chemo- and immunotherapy of transplantable and spontaneous murine leukemia. Proc Am Assoc Cancer Res (abstr #331) 13: 83, 1972

    Google Scholar 

  18. Jasmin C, Piton C, Rosenfeld C: Effets de l'iodoacétamide sur les cellules de la leucémie virale de Rauscher. Int J Cancer 3:254, 1968

    Article  PubMed  CAS  Google Scholar 

  19. Klein G: Recent trends in tumor immunology. Isr J Med Sci 2:135, 1966

    PubMed  CAS  Google Scholar 

  20. Mathé G: Secondary syndrome: A stumbling block in the treatment of leukemias by whole body irradiation and transfusion of allogeneic hematopoietic cells, Diagnosis and Treatment of Acute Radiation Injury. Geneva, World Health Organization, 1961, volume I, p 191

    Google Scholar 

  21. Mathé G: Immunothérapie active de la leucémie L 1210 appliquée après la greffe tumorale. Rev Fr Etud Clin Biol 13:881, 1968

    PubMed  Google Scholar 

  22. Mathé G: Are the neoantigens induced by chemical carcinogens or by leukaemogenic viruses particular to cancer cells? Transpl Proc 1:113, 1969

    Google Scholar 

  23. Mathé G: First and recent experimental and clinical results of the active immunotherapy of leukemia (in press)

  24. Mathé G: A screening for immunity systemic adjuvants. Cancer, in press, 1973

  25. Mathé G, Amiel JL: Reduction de la concentration plasmatique du virus leucémigene de Charlotte Friend par immunothérapie adoptive (greffe de moelle osseuse allogenigue). CR Acad Sci 259:4408, 1964

    Google Scholar 

  26. Mathe G, Amiel JL, Bernard J: Traitement de souris AkR à l'âge de six mois par irradiation totale suivie de transfusion de cellules hématopoiétiques allogéniques. Incidences respectives de la leucémie et du syndrome secondaire. Bull Cancer 47:331, 1960

    CAS  Google Scholar 

  27. Mathé G, Amiel JL, Friend C: Essai de traitement de la leucémie de Charlotte Friend par la greffe de cellules hématopoiétiques de donneurs isogéniques vaccinés contre le virus. Bull Cancer 49:416, 1962

    Google Scholar 

  28. Mathé G, Amiel JL, Niemetz J: Greffe de moelle osseuse après irradiation totale chez des souris leudémiques, suivie de l'administration d'un antimitotique pour réduire la fréquence du syndrome secondaire et ajouter à l'effet antileucemique. CR Acad Sci 254:3603, 1962

    Google Scholar 

  29. Mathé G, Amiel JL, Schwarzenberg L, et al: Successful allogenic bone marrow transplantation in man: Chimerism, induced specific tolerance and possible anti-leukemic effects. Blood 25:179, 1965

    PubMed  Google Scholar 

  30. Mathé G, Amiel JL, Schwarzenberg L, et al: Démonstration de l'efficacité de l'immunothérapie active dans la leucémia aiguë lymphoblastique humaine. Rev Fr Etud Clin Biol 13:454, 1968

    PubMed  Google Scholar 

  31. Mathé G, Amiel JL, Schwarzenberg L, et al: Active immunotherapy for acute lymphoblastic leukemia. Lancet 1:697, 1969

    Article  PubMed  Google Scholar 

  32. Mathé G, Amiel JL, Schwarzenberg L, et al: Bone marrow transplantation in man. Transpl Proc 1:16, 1969

    Google Scholar 

  33. Mathé G, Amiel JL, Schwarzenberg L, et al: Les diverses approches immunologiques du traitment des cancers humains. Les premiers pas de l'immunothérapie active, C.R. 37e Congrès français de médecine. Paris, Masson, 1969, volume 1, p 161

    Google Scholar 

  34. Mathé G, Amiel JL, Schwarzenberg L, et al: Preliminary result of a new protocol for the active immunotherapy of acute lymphoid leukaemia: Inhibition of the immunotherapeutic effect by vincristine or adamantadine. Rev Eur Etud Clin Biol 16:216, 1971

    PubMed  Google Scholar 

  35. Mathé G, Bernard J: Essai de traitement, par l'irradiation X suivie de l'administration de cellules myéloïdes homologues, de souris AK atteintes de leucémie spontanée très avancée. Bull Cancer 45:289, 1958

    Google Scholar 

  36. Mathé G, Bernard J: Essai de traitement de la leucémie greffée 1210 par l'irradiation X suivie de transfusion de cellules hématopoïetiques normales (isologues ou homologues, myéloïdes, ou lymphoïdes, adultes ou embryonnaires). Rev Fr Etud Clin Biol 4:442, 1959

    PubMed  Google Scholar 

  37. Mathé G, Bernard J, Schwarzenberg L, et al: Essai de traitement de sujets atteints de leucémie aique en remission par irradiation totale suivie de transfusion de moelle osseuse homologue. Rev Fr Etud Clin Biol 4:675, 1959

    PubMed  Google Scholar 

  38. Mathé G, Bernard J, de Vries MJ, et al: Nouveaux essais de greffe de moelle osseuse homologue après irradiation totale chez des enfants atteints de leucémie aigue en rémission: Le problème du syndrome secondaire chez l'homme. Rev Hematol 15:115, 1960

    PubMed  Google Scholar 

  39. Mathé G, Dausset J, Hervet E, et al: Immunological studies in patients with placental choriocarcinoma. J Natl Cancer Inst 33:193, 1964

    PubMed  Google Scholar 

  40. Mathé G, Halle-Pannenko O, Bourut C: Active immunotherapy of spontaneous AkR leukemia (in press)

  41. Mathé G, Pouillart P, Lapeyraque F: Active immunotherapy of L1210 leukaemia applied after the graft of tumor cells. Br J Cancer 23:814, 1969

    PubMed  Google Scholar 

  42. Mathé G, Pouillart P, Lapeyraque F: Active immunotherapy of mouse RC 19 and E ♀ Kl leukaemias applied after the intravenous transplantation of the tumour cells. Experientia 27:446, 1971

    Article  PubMed  Google Scholar 

  43. Mathé G, Schwarzenberg L: Immunotherapie adoptive locale de la leucémie L 1210 ascitique. Analyse des facteurs de son efficacité. Eur J Cancer 4:211, 1968

    PubMed  Google Scholar 

  44. Mathé G, Schwarzenberg L, Amiel JL et al: Experimental basis and clinical results of leukemia adoptive immunotherapy. Advances in the Treatment of Acute (Blastic) Leukemias. Heidelberg, Springer-Verlag, 1970, no. 30, p 76

    Google Scholar 

  45. Mathé G, Schwarzenberg L, de Vries MJ, et al: Les divers aspects du syndrome secondaire compliquant les transfusions allogéniques de moelle osseuse ou de leucocytes chez des sujets atteints d'hémopathies malignes. Eur J Cancer 1:75, 1965

    PubMed  Google Scholar 

  46. Motta R: The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens. Rev Eur Etud Clin Biol 15:161, 1970

    PubMed  CAS  Google Scholar 

  47. Motta R: Passive immunotherapy of leukemia and other cancer. Adv Cancer Res 14:161, 1971

    Article  PubMed  CAS  Google Scholar 

  48. Old LJ, Boyse EA: Immunology of experimental tumors. Annu Rev Med 15:167, 1964

    Article  PubMed  CAS  Google Scholar 

  49. Prager MD, Ticaric S, Merrill CL: Tumor-host relationship in immune response to modified lymphoma cells. Proc Am Assoc Cancer Res (abstr #411) 13:103, 1972

    Google Scholar 

  50. Prehn RT: Tumor specific immunity to nonviral tumors. Can Cancer Conf 5:387, 1963

    PubMed  CAS  Google Scholar 

  51. Robinson E, Ben-Hur N, Zuckerman H, et al: Further immunologic studies in patients with choriocarcinoma and hydatidiform mole. Cancer Res 27:1202, 1967

    PubMed  CAS  Google Scholar 

  52. Schwarzenberg L, Mathé G, Schneider M, et al: Attempted adoptive immunotherapy of acute leukaemia by leucocyte transfusions. Lancet 2:365, 1966

    Article  PubMed  CAS  Google Scholar 

  53. Skipper HE, Schabel FM, Wilcox WS: Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic associated with “curability” of experimental leukemia. Cancer Chemother Rep 35:3, 1964

    Google Scholar 

  54. Skipper HE, Schabel FM, Wilcox WS: Experimental evaluation of potential anticancer agents. IV. Further study of certain basic concepts underlying chemotherapy of leukemia. Cancer Chemother Rep 45:5, 1965

    PubMed  CAS  Google Scholar 

  55. Skipper HE, Schabel FM, Wilcox WS: Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep 51:125, 1967

    PubMed  CAS  Google Scholar 

  56. Thompson RB, Alberola V, Mathé G: Evaluation of surgery chemotherapy and immunotherapy on the Lewis lung tumor. Eur J Clin Biol Res 17:900, 1972

    CAS  Google Scholar 

  57. Woodruff MF, Boak JL: Inhibitory effect of pre-immunized CBA spleen cells on transplants of A-strain mouse mammary carcinoma in (CBA x A) F1 hybrid recipients. Br J Cancer 19:411, 1965

    PubMed  CAS  Google Scholar 

  58. Woodruff MF, Nolan B: Preliminary observations on treatment of advanced cancer by injection of allogeneic spleen cells. Lancet 2:426, 1963

    Article  PubMed  CAS  Google Scholar 

  59. Woodruff MF, Symes MO: The use of immunologically competent cells in the treatment of cancer: Experiments with a transplantable mouse tumour. Br J Cancer 16:707, 1962

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Cancérologie et d'Immunogénétique, Hôpital Paul-Brousse, 94-Villejuif, Paris, France

    Georges Mathé M.D. & Robert B. Thompson M.D.

Authors
  1. Georges Mathé M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert B. Thompson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

“Local immunotherapy” realized by the intratumoral application of agents to modify thein situ state of immunity is not considered in this review.

About this article

Cite this article

Mathé, G., Thompson, R.B. Immunology and colonic cancer: Cancer immunotherapy results in leukemias-experimental and clinical approaches to the treatment of solid tumors. Dis Colon Rectum 16, 341–357 (1973). https://doi.org/10.1007/BF02587576

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02587576

Keywords

Search

Navigation